Cargando…

Recent Scientific Developments in Metastatic Prostate Cancer

Detalles Bibliográficos
Autor principal:	Heidegger, Isabel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7694445/ https://www.ncbi.nlm.nih.gov/pubmed/33171897 http://dx.doi.org/10.3390/cancers12113280

Ejemplares similares

Radium-223 for metastatic castration-resistant prostate cancer: results and remaining open issues after the ALSYMPCA trial
por: Heidegger, Isabel, et al.
Publicado: (2018)

Cholesterol pathway the Achilles heel in prostate cancer metastasis
por: Heidegger, Isabel, et al.
Publicado: (2018)

Recent Insights on Genetic Testing in Primary Prostate Cancer
por: Kafka, Mona, et al.
Publicado: (2021)

Treatment of metastatic prostate cancer after STAMPEDE
por: Wolf, Philipp
Publicado: (2017)

Non-invasive actionable biomarkers for metastatic prostate cancer
por: Luo, Jun
Publicado: (2016)

Metastatic hormone-sensitive prostate cancer: How should it be treated?
por: López-Campos, Fernando, et al.
Publicado: (2021)

Prostate radiotherapy for metastatic hormone sensitive prostate cancer—myth or reality?
por: Onal, Cem
Publicado: (2019)

Recent Advances in Insect Rearing Methodology to Promote Scientific Research and Mass Production
por: Huynh, Man P., et al.
Publicado: (2021)

The earlier the better? Apalutamide for non-metastatic castration resistant prostate cancer
por: De Santis, Maria, et al.
Publicado: (2019)

Should Early Use of Chemotherapy Be Avoided in the Treatment of Metastatic Prostate Cancer?
por: Kimura, Takahiro
Publicado: (2021)

New insights for drug resistance in metastatic castration-resistant prostate cancer
por: Kushwaha, Prem Prakash, et al.
Publicado: (2022)

Special Issue “Prostate Cancer: Recent Advances in Diagnostics and Treatment Planning”
por: Tokas, Theodoros
Publicado: (2022)

Rapid bench to bed in management of metastatic prostate cancer
por: Balaji, K. C.
Publicado: (2016)

KDM5D predicts response to docetaxel chemotherapy in metastatic castration resistant prostate cancer patients
por: Schäfer, Georg, et al.
Publicado: (2021)

How to deal with steroids use in the management of metastatic prostate cancer during pandemic
por: Baboudjian, Michael, et al.
Publicado: (2020)

Metastatic extent predicts survival as patients with metastatic castration-resistant prostate cancer are treated with (177)Lu-PSMA radioligand therapy
por: von Eyben, Finn Edler, et al.
Publicado: (2020)

Experiencing COVID19 pandemic and neurology: learning by the recent reports and by old literary or scientific descriptions
por: Federico, Antonio
Publicado: (2020)

Pandemics and the development of scientific methods in the history of epidemiology
por: Morabia, Alfredo
Publicado: (2020)

Screening for functional kinases in metastatic prostate cancer: a glimmer of hope for kinase inhibition
por: Ornstein, Moshe C., et al.
Publicado: (2016)

Radiotherapy to the Primary Tumor: The First Step of a Tailored Therapy in Metastatic Prostate Cancer
por: Ferro, Matteo, et al.
Publicado: (2022)

Will the Development of the Japanese Cancer Literacy Assessment Tool Lead to Cancer Awareness Activities with Scientific Evidence?
por: Nakayama, Tomio
Publicado: (2022)

Recent developments in the treatment of metastatic colorectal cancer
por: Loree, Jonathan M., et al.
Publicado: (2017)

Ten Simple Rules for the Open Development of Scientific Software
por: Prlić, Andreas, et al.
Publicado: (2012)

The role of scientific publishing in the development of early career investigators
por: Cuker, Adam, et al.
Publicado: (2017)

Treatment intensification for metastatic prostate cancer: New treatment landscapes in androgen deprivation‐based therapy
por: Turco, Fabio, et al.
Publicado: (2022)

Editorial Policy, DOI and (in)visibility of scientific publications
por: Araújo, Agostinho Antônio Cruz, et al.
Publicado: (2022)

Recent Trends in Cancer Genomics and Bioinformatics Tools Development
por: Anashkina, Anastasia A., et al.
Publicado: (2021)

Recent Developments in NAFLD
por: Mantovani, Alessandro, et al.
Publicado: (2022)

Editorial Practices, Scientific Impact, and Scientific Quality
por: Andersen, Olaf Sparre
Publicado: (2008)

Developing immunotherapy strategies in the treatment of prostate cancer
por: Gulley, James L., et al.
Publicado: (2016)

Editorial on an international survey of androgen deprivation therapy (ADT) for non-metastatic prostate cancer in 19 countries
por: Sternberg, Cora N
Publicado: (2016)

Molecular Targeted Therapies in Metastatic Prostate Cancer: Recent Advances and Future Challenges
por: Sorrentino, Carlo, et al.
Publicado: (2023)

Scientific Insights and Technological Advances in Gluten-Free Product Development
por: Papageorgiou, Maria, et al.
Publicado: (2023)

Novel concepts of antiangiogenic therapies in metastatic renal cell cancer
por: Pichler, Renate, et al.
Publicado: (2017)

Local therapy in patients with metastatic prostate cancer: a new standard of care?
por: Harper, Benjamin, et al.
Publicado: (2019)

Recent developments in chemical diversity
por: Porco, John A
Publicado: (2012)

Recent data and developments in myositis
por: Stenzel, Werner, et al.
Publicado: (2021)

Epidemiology of suicide: recent developments
por: Baldessarini, Ross J.
Publicado: (2019)

Lessons from the SWITCH trial: changing glucocorticoids in the management of metastatic castration-resistant prostate cancer (mCRPC)
por: Teo, Min Yuen, et al.
Publicado: (2018)

Insights into the prognostic potential of total alkaline phosphatase in metastatic castration-resistant prostate cancer treated with radium-223
por: Viani, Gustavo
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_aktrhclvv1cg9cs2tqrlks95s0